EMPAA L 10/5MG 28`S

EMPAA L is a combination medication containing Empagliflozin 10mg and Linagliptin 5mg, designed to help manage type 2 diabetes. This dual-action formula works by improving insulin sensitivity and reducing blood sugar levels through two complementary mechanisms. Empagliflozin helps your kidneys remove excess glucose through urine, while Linagliptin enhances your body's natural insulin response. Each pack contains 28 tablets for convenient monthly dosing. Ideal for patients requiring enhanced glycemic control, EMPAA L offers a simplified treatment approach in a single tablet. Always use as directed by your healthcare provider.